By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Mydriatics > Isopto atropine > Atropine Ophthalmic Dosage
Mydriatics
https://themeditary.com/dosage-information/atropine-ophthalmic-dosage-2970.html

Atropine Ophthalmic Dosage

Drug Detail:Isopto atropine (Atropine ophthalmic [ a-troe-peen ])

Drug Class: Mydriatics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Refraction

Eye drops:

  • Instill 1 drop into eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop in each eye twice a day

Comments:
  • To minimize systemic absorption, the lacrimal sac should be compressed with digital pressure for 1 minute after instillation.

Use: For refraction and examination of fundus by inducing mydriasis and cycloplegia.

Usual Adult Dose for Uveitis

Ointment:

  • Instill a small amount into the conjunctival sac once or twice a day.

Eye drops:
  • Instill 1 drop into eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop in each eye twice a day

Comments:
  • To minimize systemic absorption, the lacrimal sac should be compressed with digital pressure for 1 minute (eye drops) to 3 minutes (ointment) after instillation.

Use: For pupillary dilation desired in inflammatory conditions of the iris and uveal tract.

Usual Adult Dose for Iritis

Ointment:

  • Instill a small amount into the conjunctival sac once or twice a day.

Eye drops:
  • Instill 1 drop into eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop in each eye twice a day

Comments:
  • To minimize systemic absorption, the lacrimal sac should be compressed with digital pressure for 1 minute (eye drops) to 3 minutes (ointment) after instillation.

Use: For pupillary dilation desired in inflammatory conditions of the iris and uveal tract.

Usual Pediatric Dose for Pupillary Dilation

3 years or older:

  • Instill 1 drop into eye(s) as required for treatment
Maximum dose: 1 drop in each eye twice daily

Ointment:
  • Instill a small amount into the conjunctival sac once or twice a day.

Comments:
  • Systemic absorption can be minimized by applying pressure to the lacrimal duct for 1 minute (eye drop) to 3 minutes (ointment) during and after instillation.

Use: For the treatment of amblyopia by penalization of the healthy eye.

Usual Pediatric Dose for Refraction

Eye drops:
3 months to 3 years:

  • Instill 1 drop into the eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop per eye per day

3 years or older:
  • Instill 1 drop into eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop in each eye twice a day

Ointment:
  • Instill a small amount into the conjunctival sac once or twice a day.

Comments:
  • Systemic absorption can be minimized by applying pressure to the lacrimal duct for 1 minute (eye drop) to 3 minutes (ointment) during and after instillation.

Use: For refraction and examination of fundus by inducing mydriasis and cycloplegia.

Usual Pediatric Dose for Uveitis

Eye drops:
3 months to 3 years:

  • Instill 1 drop into the eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop per eye per day

3 years or older:
  • Instill 1 drop into eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop in each eye twice a day

Ointment:
  • Instill a small amount into the conjunctival sac once or twice a day.

Comments:
  • Systemic absorption can be minimized by applying pressure to the lacrimal duct for 2 to 3 minutes after instillation.

Use: For pupillary dilation desired in inflammatory conditions of the iris and uveal tract.

Usual Pediatric Dose for Iritis

Eye drops:
3 months to 3 years:

  • Instill 1 drop into the eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop per eye per day

3 years or older:
  • Instill 1 drop into eye(s) 40 minutes prior to intended maximal dilation
Maximum dose: 1 drop in each eye twice a day

Ointment:
  • Instill a small amount into the conjunctival sac once or twice a day.

Comments:
  • Systemic absorption can be minimized by applying pressure to the lacrimal duct for 2 to 3 minutes after instillation.

Use: For pupillary dilation desired in inflammatory conditions of the iris and uveal tract.

Renal Dose Adjustments

No adjustment recommended

Liver Dose Adjustments

No adjustment recommended

Dose Adjustments

Use caution in inflamed eyes as hyperemia greatly increases the rate of systemic absorption through the conjunctiva.

Heavily pigmented irides are more resistant to pupillary dilation; use caution to avoid overdose

Systemic absorption can be minimized by applying pressure to the lacrimal duct for 1 minute (eye drop) to 3 minutes (ointment) during and after instillation.

Precautions

Safety and efficacy have not been established in patients younger than 3 months.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For ophthalmic use only; not for injection
  • Contact lenses should be removed before use.
  • Instill drops into the eye at the cul-de-sac of the conjunctiva; systemic absorption may be minimized by applying pressure to the lacrimal duct for 1 minute during and after instillation
  • Apply ointment into conjunctiva sac; systemic absorption may be minimized by applying pressure to the lacrimal duct for up to 3 minutes during and after instillation
  • Wash hands after administration to avoid accidental oral ingestion.

Storage requirements:
  • Store at 20C to 25C (68F to 77F); keep container tightly closed.

General:
  • Complete recovery from mydriasis may take up to 1 week or longer.

Patient advice:
  • Patients should be advised to apply pressure to the lacrimal sac for 1 minute (eye drop) to 3 minutes (ointment) during and after instillation, to minimize systemic absorption (especially in children).
  • Patients should be warned about oral toxicity, and advised to wash their hands after use and avoid getting the product in the mouth.
  • Patients should be instructed not to touch the dropper or tube tip to any surface as this may contaminate the solution or ointment.
  • Patients should be informed that complete recovery from dilation may take up to 1 week or longer; patients should be advised to protect eyes from bright light during dilation and not to drive or perform potentially hazardous activities while pupils are dilated.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by